Viewing Study NCT06552858


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-01-02 @ 11:13 AM
Study NCT ID: NCT06552858
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-14
First Post: 2024-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module